Naproxen / sumatriptan Alternatives Compared
| Naproxen / sumatriptan | Ubrelvy (ubrogepant) | Symbravo (meloxicam / rizatriptan) |
|
|---|
| Naproxen / sumatriptan | Ubrelvy (ubrogepant) | Symbravo (meloxicam / rizatriptan) |
|
|||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Migraine. Naproxen / sumatriptan may also be used for purposes not listed in this medication guide. |
Prescription only
Ubrelvy is a prescription medicine that may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine... View more |
Prescription only
Prescribed for Migraine. Symbravo may also be used for purposes not listed in this medication guide. |
Related suggestionsMigraine |
|||||||||||||||||||||||||||||
| More about Naproxen / sumatriptan | More about Ubrelvy (ubrogepant) | More about Symbravo (meloxicam / rizatriptan) | ||||||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||||||||
|
Naproxen / sumatriptan has an average rating of 9.1 out of 10 from a total of 99 ratings on Drugs.com. 91% of reviewers reported a positive effect, while 5% reported a negative effect. |
Ubrelvy has an average rating of 6.8 out of 10 from a total of 338 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 29% reported a negative effect. |
Symbravo has an average rating of 9.5 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||||||||
|
View all 99 reviews |
View all 338 reviews |
View all 2 reviews |
||||||||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||||||||
View all side effects |
View all side effects |
View all side effects |
||||||||||||||||||||||||||||||
| Boxed Warnings A boxed warning is the most serious warning from the Food and Drug Administration (FDA) about drug effects that may be dangerous. | ||||||||||||||||||||||||||||||||
|
View boxed warnings |
N/A |
View boxed warnings |
||||||||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||||||||
| Generic Availability Learn more about brand vs generic drugs. | ||||||||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance. | ||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||||||||
| Treximet |
N/A |
N/A |
||||||||||||||||||||||||||||||
| Half Life Learn about the half-life of a drug and how it is calculated. | ||||||||||||||||||||||||||||||||
|
19 hours |
7 hours |
20 hours |
||||||||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||||||||
|
Category C
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||||||||
|
A total of 626 drugs are known to interact with Naproxen / sumatriptan:
|
A total of 270 drugs are known to interact with Ubrelvy:
|
A total of 687 drugs are known to interact with Symbravo:
|
||||||||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||||||||
|
April 15, 2008 |
December 23, 2019 |
January 30, 2025 |
||||||||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.